Global Endurance Portfolio ABUS Holdings History
Global Endurance Portfolio's Arbutus Biopharma Corp Holding Summary
As of 2025-03-31, MORGAN STANLEY INSTITUTIONAL FUND INC held 402,875.00 shares of Arbutus Biopharma Corp(ABUS), totaling $1.41 Mil. This investment constitutes 5.3% of their stock portfolio, and MORGAN STANLEY INSTITUTIONAL FUND INC now holds 0.21% of the outstanding Arbutus Biopharma Corp(ABUS) stock.
The initial trade took place in 2023Q1. And since then Global Endurance Portfolio has made 5 purchases of ABUS, at an average price of $3.01, for a total of 483,183.00 shares. In addition, there have been 2 sales at an average price of $3.69 for 80,308.00 shares. Based on historical transaction data and ABUS's current price of $3.23, Global Endurance Portfolio's estimated gain on his ABUS holdings is $144,648.44, reflecting a 9.96% gain to date.
Global Endurance Portfolio ABUS ($3.23) Holding Chart
Global Endurance Portfolio ABUS ($3.23) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
